Изменение активности пролинспецифических пептидаз мозга при экспериментальном моделировании амнезии
Диссертация
В настоящем исследовании проведено изучение роли пролинспецифических пептидаз мозга — пролилэндопептидазы и дипептидилпептидазы IV — в механизмах нарушений памяти. У животных с ретроградной амнезией, вызванной максимальным электрошоком, а также однократным системным введением скополамина, проявлявшейся в уменьшении латентного времени захода в темную камеру в тесте условного рефлекса пассивного… Читать ещё >
Список литературы
- Аведисова, А.С., Ахапкин, Р.В., Ахапкина, В.И., Вериго Н. Н. Пирацетам в свете современных исследований (анализ зарубежных исследований) // Психиатрия и психофармакотерапия. 2000. — Т. 2 -N 6 — С. 178−184.
- Анохин, К.В. Молекулярные сценарии консолидации долговременной памяти // Журнал высшей нервной деятельности. 1997. — Т. 47. — В. 2. — С. 261−279.
- Антонова, М. И., Прокопов, А. А., Ахапкина, В. И., Берлянд, А. С. Экспериментальная фармакокинетика фенотропила у крыс // Химико-фармацевтический журнал. 2003. — Т.37. — № 11. С. 7−8.
- Ахапкина, В. И. Воронина Т.А., Спектр фармакологических эффектов Фенотропила // Фарматека. 2005. — № 13. — - С. 19−25.
- Нейрохимия. Под ред. Акад. РАМН Ашмарина И. П. и проф. Стукалова П. В. Москва: Изд. Института Биомедицинской химии РАМН. 1996. -470 с.
- Воробьева, О.В. Возможности использования препарата Омарон®- для лечения цереброваскулярной болезни // Медицинский вестник 2007. — № 14 — С.18−23
- Воронина, Т.А., Середенин, С. Б. Перспективы поиска новых анксиолитиков // Эксперим. и клин. Фармакология. 2002. — Т. 65 — № 5 -С. 4−17.
- Воронина, Т.А., Середенин, С. Б. Ноотропные и нейропротекторные средства // Эксперим. и клин. Фармакология. 2007. — Т.70. — № 4. — С. 4458.
- Гаврилова, С.И. Практическое, руководство по диагностике и лечению болезни Альцгеймера. / М. 2002. — 42 с.
- Гомазков, О. А. Нейромедиаторы, пептиды и нейротрофины в патогенезе болезни Альцгеймера (Нейротрофические факторы мозга) Справочно-информационное издание. Электронная версия. М.2004.
- Греченко, Т.Н. Психофизиология: Учебное пособие. — М.: Гардарики, 1999. —356 с.
- Гроппа, С.В. Медикаментозная коррекция болезни Альцгеймера // Ж. Невропатологии и Психиатрии. 1991. — Т.91. — № 9. — С. 110−116.
- Дамулин, И.В. Новая нейропротективная и терапевтическая стратегия при деменциях: антагонист NMDA-рецепторов Акатинол Мемантин. // Русск. мед. журн. —2001. -Т.9- N 25. -С. 1178−1182.
- Дамулин, И.В., Яхно, Н.Н. Сосудистая мозговая недостаточность у пациентов пожилого и старческого возраста (клинико-компьютерно-томографическое исследование). // Ж. Невропатологии и Психиатрии. -1993.-T.93.-N2. -С.10−13.
- Данилова, Н.Н. Психофизиология / М.: Аспект Пресс, 2001.- 372 с.
- Диксон, М., Уэбб, Э. Ферменты. М.: Мир, 1966. — 816 с.
- Ещенко, Н.Д. Биохимия психических и нервных болезней. / СПб. — 2004 204 с.
- Жмуров, В.А. Психопатология. М.: Медицинская книга. — 2002. — 668 с.
- Захаров, В.В. Применение танакана в нейрогериартрической практике // Неврологический журнал.-1997.-Т.5 -С.42−49.
- Захаров, В.В., Ахутина, Т.В., Яхно, Н. Н. Нарушение памяти при болезни Паркинсона. //Ж. Неврологии и Психиатрии. 1999. -Т.99. — № 4. -С. 17−22.
- Захаров, В.В., Дамулин, И.В., Яхно, Н. Н. Медикаментозная терапия деменций. //Ж. Клиническая фармакология и терапия. 1994. -Т.З. — № 4. -С. 69−75.
- Захаров, В.В., Яхно, Н.Н. Нарушение памяти. М.: ГЭОТАР-МЕД, 2003. — 160 с.
- Золотов Н.Н. Структурно-функциональный подход к созданию фармакологически активных веществ на основе ингибиторов пептидаз. Автореферат диссертации на соискание ученой степени д.б.н. Москва, 1997. 48 с.
- Золотов Н.Н., Наркевич В. Б., Позднев В. Ф., Прихожан А. В., Воронина Т. А., Раевский К. С. О психотропных свойствах ингибиторовпролилэндопептидазы мозга. П Доклады академии наук СССР 1992. -Т.322. — С.776−779.
- Кендел, Э., Хокине, Р. Биологические основы обучения и индивидуальности.// Ж. В мире науки.- 1992.- N 11−12. С.43−51.
- Кругликов Р.И. Нейрохимические основы обучения и памяти. //М.: Наука 1989 — 160 с.
- Крупина Н.А., Крыжановский Г. Н. Недостаточность дофаминергической нигростриатной системы как дизрегуляционный механизм дофаминзависимого депрессивного синдрома // Журн. неврологии и психиатрии им. С. С. Корсакова. 2003. — № 4. — С. 42−47.
- Крыжановский, Г. Н. Дизрегуляционная патология. М.:ЗАО «РИТ-ЭКСПРЕСС» 2002. — 96 с.
- Крыжановский, Г. Н. Дизрегуляционная патология // Дизрегуляционная патология. -М.: Медицина, 2002. С. 18−78.
- Литвин, О.О., Анохин, К.В. Механизмы реорганизации памяти во время воспроизведения приобретенного поведенческого опыта у цыплят: эффекты блокады синтеза белка в мозге // Журнал высшей нервной деятельности. 1999. — Т. 49. — N 4. — 554−565.
- Международная статистическая классификация болезней и проблем, связанных со здоровьем. Десятый пересмотр., Женева: ВОЗ. 1995. — Т. 1. -Ч. 2. -С.210.
- Муравьева, Е.В., Анохин, К.В.Участие синтеза белка в реконсолидации памяти в разное время после обучения условнорефлекторному замиранию у мышей // Журнал высшей нервной деятельности.- 2006.- Т. 56. № 2. -С.274−281.
- Пресс-бюллетень Информационного Центра ООН в Москве. 2007. 20 июня // http://www.unic.ru/bill/ .
- Романова, Г. А. Дизрегуляционные нарушения интегративной деятельности мозга при фокальной ишемии коры // В кн.: Дизгуляционная патология под ред. Г. Н. Крыжановского 2002 — С. 605−614.
- Романова, Г. А., Шакова, Ф.М. Дизрегуляция когнитивных функций при локальной ишемии префронтальной коры головного мозга крыс // Нейронауки. 2006. — Т. 3. — № 5. — С. 10−16.
- Руководство по экспериментальному (доклиническому) изучению новых фармакологических веществ. Москва: Минздрав РФ, ЗАО «ИИА „Ремедиум“». 2000. — С. 153−154.
- Титов, А.А. Нейрохимические основы памяти// В. Кн. Биохимия мозга. Ред. Ашмарин И. П., Стукалов П. В. и Ещенко Н. Д. Изд. СПб. ГУ. 1999. -С.284−285.
- Шевченко, В. П. Нагаев И. Ю., Алфеева JI. Ю., Андреева JI. А., Климова П. А., Шевченко К. В., Малкин А. В., Мясоедов Н. Ф. Синтез меченого тритием семакса Радиохимия. 2006 — Т. 48. — В. 3. — С. 260−266.
- Шугалев, Н.П., Ставровская, А.В., Ольшанский, А.С., Хартманн, Г., Ленард, JI. Вовлечение серотонинергических структур мозга в эффекты нейротензина на пассивное избегание у крыс // Журн. высшей неврн. деят. 2007 — Т. 57. — № 3. — С.352−357.
- Энциклоп.слов.мед.терм. Под ред. акад РАМН В. И. Покровскпй Изд.второе.М:Медицина. -2001. С. 32, 568.
- Яхно, Н.Н. Актуальные вопросы нейрогериатрии. / В сб.: Достижения в нейрогериатрии. Под ред. Н. Н. Яхно, И. В. Дамулина. -М.: ММА, 1995. -Ч. 1.-С. 9−29.
- Яхно, Н.Н., Захаров, В.В. Легкие когнитивные нарушения в пожилом возрасте. //Неврологический журнал. -2004. -№ 1. С. 3−9.
- Яхно, Н.Н., Лавров, А.Ю. Изменения центральной нервной системы при старении. Нейродегенеративные болезни и старение (Руководство дляврачей). Под ред. И. А. Завалишина, Н. Н. Яхно, С. И. Гавриловой. М. 2001 -С. 242−261.
- Яхно, Н.Н., Преображенская, И.С. Болезнь Альцгеймера: патогенез, клиника, лечение // Русск. мед. журн. -2002. -Т.10. -N 25. -С. 1143−1146.
- Abe, Е., Murai, S., Masuda, Y. Saito, H., Itoh, Т. Alpha-sialyl cholesterol reverses AF64A-induced deficit in passive avoidance response and depletion of hippocampal acetylcholine in mice // Br. J. Pharmacol. 1993. — V. 108. — N 2. -P. 387−392.
- Abelson, J.N., Simon, M.I., Barrett A.J. (eds.) Methods in Enzymology (vol. 244) Proteolytic Enzymes: Serine and Cysteine Peptidases. 2004. — P. 188−200.
- Agirregoitia, N, Gil, J, Ruiz, F, Irazusta, J, Casis, L. Effect of aging on rat tissue peptidase activities. J Gerontol A Biol Sci Med Sci. 2003. — V. 58. — N 9.-P. 792−797.
- Agirregoitia, N., Irazusta, A., Ruiz F., Irazusta, J., Gil, J. Ontogeny of soluble and particulate prolyl endopeptidase activity in several areas of the rat brain and in the pituitary gland // Dev. Neurosci. 2003b. — V. 25. — N 5. — P. 316−323.
- Agirregoitia, N., Casis, L., Gil, J., Ruiz, F., Irazusta, J. Ontogeny of prolyl endopeptidase and pyroglutamyl peptidase I in rat tissues // Regul. Pept. 2007. -V. 139.-N 1−3.-P. 52−58.
- Albiston, A.L., Fernando, R., Siying, Y.E., Peck, G.R., Siew Yeen Chai. Alzheimer’s, Angiotensin IV and an Aminopeptidase // Biol. Pharm. Bull. -2004. V.27. — N 6. — P. 765 — 767.
- Aoyagi, Т., Wada, Т., Nagai, M., Kojima, F., Harada, S., Takeuchi, Т., Takahashi, H., Hirokawa, K., Tsumita, T. Deficiency of kallikrein-like enzyme activities in cerebral tissue of patients with Alzheimer’s disease.
- Experientia. 1990. — V. 46. — N. 1. — P. 94−97.
- Avila, R., Bottino, C.M. Cognitive changes update among elderly with depressive syndrome // Rev. Bras. Psiquiatr. 2006. — V. 28. — N 4. — P. 316 320.
- Barelli, H., Petit, A., Hirsch, E., Wilk, S., De Nanteuil, G., Morain, P., Checler, F. S 17 092−1, a highly potent, specific and cell permeant inhibitor of human proline endopeptidase // Biochem. Biophys. Res. Commun. 1999. -V.257.-N3.-P. 657−661.
- Barense, M.D., Fox, M.T., Baxter, M.G. Aged Rats Are Impaired on an Attentional Set-Shifting Task Sensitive to Medial Frontal Cortex Damage in Young Rats // Learn. Mem. 2002. -V. 9. — P. 191−201.
- Beckwith, B.E., Petros, T.V., Couk, D.I., Tinius T.P. The Effects of Vasopressin on Memory in Healthy Young Adult Volunteers // Annals of the New York Academy of Sciences // V. 579 A Decade of Neuropeptides: 1990Past, Present, and Future Page 215−226.
- Bellemiire, G., Vaudry, H., Morain, P., Jiigou, S. Effect of prolyl endopeptidase inhibition on arginine-vasopressin and thyrotrophin-releasing hormone catabolism in the rat brain.: J. Neuroendocrinol. -2005. V. 17 — P. 306−313.
- Bellemiire, G., Morain, P., Vaudry H., Jergou, S. Effect of SI7092, a novel prolyl endopeptidase inhibitor, on substance P and a-melanocyte-stimulating hormone breakdown in the rat brain // Journal of Neurochemistry. 2003. — V. 84.-P. 919−929.
- Bernstein, H.G., Schiin, E., Ansorge, S., Ruse, I., Dorn, A. Immunolocalization of dipeptidyl aminopeptidase (DAP IV) in the developing human brain // Int. J. Dev. Neurosci. 1987. — V. 5. -N 3. — P. 237−242.
- Bidzseranova, А., Репке, В., Tyth, G., Telegdy, G. The effects of atrial natriuretic peptide on electroconvulsive shock-induced amnesia in rats. Transmitter-mediated action. //Neuropeptides 1991. — V.19. — N 2. -P.103−106.
- Binder, E.B., Kinkead, В., Owens, M.J., Nemeroff, CH.B. Neurotensin and Dopamine // Interactions Pharmacol Rev. 2001. — V. 53. — P.453−486.
- Bogoyevitch, M.A., Barr, R.K., Ketterman, A.J. Peptide inhibitors of protein kinases—discovery, characterisation and use // Biochim. Biophys. Acta. 2005. — V. 1754. — N 1−2. — P. 79−99.
- Bonini, J. S., BevilaquA L.R., Zinn, C.G., KerrD.S., Medina J.H. Izquierdo, I., Cammarota, M. Angiotensin II disrupts inhibitory avoidance memory retrieval // Horm. behav. 2006. — V. 50. — N 2. — P. 308−313.
- Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. // Anal. Biochem. 1976. — V.72. — P. 248−252.
- Brown, W. Taltirelin. Tanabe Seiyaku. // IDrugs. 1999. — V. 2. — N 10. -P. 1059−1068.
- Browning, K.N., Travagli, R.A. The peptide TRH uncovers the presence of presynaptic 5-HT1A receptors via activation of a second messenger pathway in the rat dorsal vagal complex // J. Physiol. 2001. — V. 531. — Pt 2. — P. 425−435.
- Caldwell, H.K., Lee, H.J., Macbeth, A.H., Young, W.S. 3rd. Vasopressin: Behavioral roles of an «original» neuropeptide // Prog. Neurobiol. 2008. -V.84. -N 1. — P.1−24.
- Campbell, S., MacQueen, G. The role of the hippocampus in the pathophysiology of major depression// J. Psychiatry Neurosci. 2004. — V. 29. -N6.-P. 417−426.
- Checler, F., Barelli, H., Dauch, P., Vincent, В., Dive, V., Beaudet, A., Daniel, E.E., Fox-Threlkeld, J.E., Masuo, Y., Vincent, J.P. Recent advances on endopeptidase-3.4.24.16. // Biochem. Soc. Trans. 1993. — V.21. — Pt 3. — N 3. -P. 692−697.
- Chen, M.F., Chiu, Т.Н., Lee E.H. Noradrenergic mediation of the memory-enhancing effect of corticotropin-releasing factor in the locus coeruleus of rats //Neuropsyschoendocrinology. 1992. — V. 17. -N 2−3. — P. 113−124.
- Chiodera, P., Volpi, R., Pilla, S., Cataldo, S., Capretti, L., Coiro, V. Effect of aging on the arginine-vasopressin response to physostigmine and angiotensin II in normal men // J. Investig Med. 2000. — V.48. — N 3. — P.203−206.
- Compte, A., Brunei, N., Goldman-Rakic, P. S., Wang, X.J. Synaptic mechanisms and network dynamics underlying spatial working memory in a cortical network model // Cereb. Cortex. 2000. V. 10. — N. 9. — P. 910−923.
- Cummings, J.L., Back, C. The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimer’s disease // Am J. Geriatr Psychiatry. 1998. — V.6. — P.64−78.
- Dall’Igna, O.P., Fett, P., Gomes, M.W., Souza, D.O., Cunha, R.A., Lara, D.R. Caffeine and adenosine A (2a) receptor antagonists prevent beta-amyloid (25−35)-induced cognitive deficits in mice // Exp. Neurol. 2007. — V. 203. -N 1. -P.241−245.
- Dauge, V., Pophillat, M., Crete, D., Melik-Parsadaniantz, S., Roques, B.P. Involvement of brain endogenous cholecystokinin in stress-induced impairment of spatial recognition memory.// Neuroscience. 2003. — V. l 18. — N 1. — P. 1923.
- Dietrich, A., Taylor, J.T., Passmore CE AVP (4−8) improves concept learning in PFC-damaged but not hippocampal-damaged rats // Brain Res. -2001.-V. 919.-N 1. -P.41−47.
- Du, A.T., Schuff, N., Kramer, J. H, Rosen, H. J, Gorno-Tempini, M.L., Rankin, K, Miller BL, Weiner MW. Different regional patterns of cortical thinning in Alzheimer’s disease and frontotemporal dementia // Brain. 2007. -V. 130. -Pt4.-P. 1159−1166.
- Easton, A., Parker, A. A cholinergic explanation of dense amnesia // Cortex.-2003. V.39.-N 4−5. — P.813−826.
- Edvinsson, L., Minthon, L., Ekman, R., Gustafson, L. Neuropeptides in cerebrospinal fluid of patients with Alzheimer’s disease and dementia with frontotemporal lobe degeneration // Dementia. 1993. — V.4. — N 3−4. — P. 167 171.
- Elvander, E., Schijtt, P.A., Sandin, J., Bjelke, В., Kehr, J., Yoshitake, Т., Ogren, S.O. Intraseptal muscarinic ligands and galanin: influence on hippocampal acetylcholine and cognition // Neuroscience. 2004. — V. 126. — N 3.-P. 541−557.
- Ennaceur, A., Michalikova, S., Chazot, P.L. Models of anxiety: responses of rats to novelty in an open space and an enclosed space // Behav Brain Res. -2006.-V. 171.-N l.-P. 26−49.
- Eustache, F., Desgranges, В., Aupee, A.M., Guillery, В., Baron JC. Functional neuroanatomy of amnesia: positron emission tomography studies // Microsc. Res. Tech. 2000. — V. 51. — N 1. — P. 94−100.
- Fisher, A., Hanin, I. Potential animal models for senile dementia of Alzheimer’s type, with emphasis on AF64A-induced cholinotoxicity // Annu Rey Pharmacol Toxicol. 1986. — V.26. — P. 161−181.
- Flood, J.F., Baker, M.L., Hernandez, E.N., Morley, J.E.
- Modulation of memory retention by neuropeptide К // Brain Res. 1990. V. 520.-N 1−2.-P. 284−290.
- Flood, J.F., Garland, J.S., Morley, J.E. Vasoactive intestinal peptide (VIP): an amnestic neuropeptide // Peptides. 1990 — V. 11. — N 5. — P. 933−938.
- Flood, J.F., Cherkin, A. Scopolamine effects on memory retention in mice: a model of dementia? //Behav. Neural. Biol. 1986 — V. 45. -N 2. — P. 169−184.
- Florijn, W.J., Hens, J.J., de Graan, P.N., Versteeg, D.H., Gispen, W.H. Effects of ACTH-(l-24) on dopamine and noradrenaline release, B-50 phosphorylation and calmodulin binding to B-50 in vitro // Life Sci. -1993. V. 52.-N 12.-P. 1013−1022.
- Fonnum, F. Radiochemical microassay for determination of choline acetyltransferase and acetylcholinesterase activities // Biochem. J. -1969. V. 115.-P. 465−472.
- Freeman, F.M., Rose, S.P.R. Scholey, A.B. Two time windows of anisomysin-induced amnesia for passive avoidance training in the day old chick //Neurobiol. Learn. Mem. 1995. — V.63 — N 3. — P.291−295.
- Galeotti N, Ghelardini C, Bartolini A. Role of 5-HT1A receptors in a mouse passive avoidance paradigm // Jpn. J. Pharmacol. 2000. — V. 84. — N 4. — P. 418−424.
- Gao, M.Q., Sun, L.G., Zhang, T. B, Teng, Z., Liu, S. Effect of lead on learn and memory and release of intracellular free Ca2+ from calcium pool in dissociated mouse hippocampal neurons // Wei Sheng Yan Jiu. 2005. — V. 3. -N 4. -P.400−402.
- Garcia-Horsman, J.A., Mannisto, P.T., Venalainen, J.I. On the role of prolyl oligopeptidase in health and disease // Neuropeptides. 2007. — V. 41. — N к — P. 1−24.
- Gerwins, P., Fredholm, B.B. ATP and its metabolite adenosine act synergistically to mobilize intracellular calcium via the formation of inositol 1,4,5-trisphosphate in a smooth muscle cell line // J. Biol. Chem. 1992. — V. 267. -N23.-P. 16 081−16 087.
- Gibbs, M. E., Hertz, L., Ng, К. T. Inhibition of short-term memory formation in the chick by blockade of extracellular glutamate uptake // Neurobiology of Learning and Memory. 2004. — V. 81. -N 2. — P. 115−119.
- Gibbs, M.E., Johnston,. G.A.R. Opposing roles for gabaa and gabac receptors in short-term memory formation in young chicks// Neuroscience. -2005.-V.131.-P. 567−576.
- Gibbs, M. E., Summers, R. J. Stimulation of 61-adrenoceptors inhibits memory consolidation in the chick // European Journal of Neuroscience. 2001. -V. 14.-N8.-P. 1369−1376.
- Gibbs, M.E., Summers, R.J. Role of adrenoceptor subtypes in memory consolidation //Progress in Neurobiology. 2002. — V. 67. — P. 345−391.
- Giovannini, M.G. The role of the extracellular signal-regulated kinase pathway in memory encoding // Rev. Neurosci. 2006. — V. 17. — N 6. — P. 619 634.
- Gold, P.E. The use of avoidance training in studies of modulation of memory storage // Behav. Neural Biol. 1986. — V. 46. — P. 81−98.
- Gottesman,* I.I., Gould, T.D. The endophenotype concept in psychiatry: etymology and strategic intentions // Am J. Psychiatry. 2003. — V. 160. — N 4. -P. 636−645.
- Grossberg, G.T. Effect of rivastigmine in the treatment of behavioral disturbances associated with dementia: review of neuropsychiatric impairment in Alzheimer’s disease // Curr. Med. Res. Opin. 2005. — V. 21. — N 10. — P. 1631−1639.
- Giilpinar, M.A., Yegen, B.C. The physiology of learning and memory: role of peptides and stress // Curr. Protein. Pept. Sci. 2004. — V. 5. — N 6. — P. 457 473.
- Hanin, I. Cholinergic toxins and Alzheimer’s disease //Ann. N. Y Acad Sci. -1992. -V. 648.-P. 63−70.
- Hatanpaa, K., Isaacs, K.R., Shirao, Т., Brady, D.R., Rapoport, S.I. Loss of proteins regulating synaptic plasticity in normal aging of the human brain and in Alzheimer disease. // J. Neuropathol Exp. Neurol. 1999. — V. 58. — N 6. — P. 637−643.
- Heinrichs, M., Meinlschmidt, G., Wippich, W., Ehlert, U., Hellhammer, D.H. Selective amnesic effects of oxytocin on human memory // Physiology & Behavior. 2004. — V. 83. — P. 31−38.
- Herzog, C.D., Stackman, R.W., Walsh, T.J. Intraseptal flumazenil enhances, while diazepam binding inhibitor impairs, performance in a working memory task // Neurobiol Learn. Mem. 1996. — V. 66. -N 3. — P.341−352.
- Hinko, A., Pearlmutter, A.F. Effects of arginine vasopressin on protein phosphorylation in rat hippocampal synaptic membranes. J Neurosci Res. -1987.-V. 17.-N 1 P. 71−79.
- Hock, F.J. Therapeutic approaches for memory impairments // Behav Brain Res. 1995. — V. 66. -N 1−2. — P. 143−150.
- Hoist, J.J., Deacon, C.F. Inhibition of the activityof dipeptidyl-peptidase IV as a treatmentfor type 2 diabetes // Diabetes. 1998. — V.47. — P. 1663−1670.
- Itoh, S., Takashima, A., Morimoto, T. Impaired spatial learning by vasoactive intestinal peptide in Morris water maze task in the rat // Can J. Physiol Pharmacol. 1994. — V.72.-N 1.-P.25−29.
- Izquierdo, I., De Almeida, M. A., Emiliano, V. R. Unlike beta-endorphin, dynorphin 1−13 does not cause retrograde amnesia for shuttle avoidance or inhibitory avoidance learning in rats // Psychopharmacology. (Berl). 1985. -V. 87. -N2.-P. 216−218.
- Izquierdo, I., Medina, J.H. Memory formation: the sequence of biochemical events in the hippocampus and its connection to activity in other brain structures //Neurobiol.Learn.Mem. 1997. -V. 68. — P. 285−316.
- Izquierdo, I., Medina, J.H., Vianna, M.R.M., Izquierdo, L.A., Barros, D.M. Separate mechanisms for short-term and long-term memory // Behavioural Brain Ressearch. 1999.-V — 103 — C. 1−111.
- Jahn, O., Radulovic, J., Stiedl, O., Tezval, H., Eckart, K., Spiess, J. Corticotropin-releasing factor binding protein—a ligand trap? // Mini Rev. Med. Chem. -2005. V. 5.-N 10.-P. 953−960.
- Jezova, D. Control of ACTH secretion by excitatory amino acids: functional significance and clinical implications // Endocrine. 2005. — V.28. — N.3. -P.287−294.
- Jiang, C.H., Tsien, J.Z., Schultz, P.G., Hu, Y. The effects of aging on gene expression in the hypothalamus and cortex of mice // Proc. Natl. Acad Sci US A.-2001.-V. 98.-N4.-P. 1930−1934.
- Jimenez-Corral, C., Moran-Sanchez JC, Alonso-Navarro H. Neuropeptides in Alzheimer’s disease // Rev Neurol. 2006. — V. 42. — N 6. — P.354−359.
- Kapoor, J.R., Sladek, C.D. Substance P and NPY differentially potentiate ATP and adrenergic stimulated vasopressin and oxytocin release // Am J. Physiol Regul. Integr. Сотр. Physiol. 2001. — V. 280. — N 1. — P. 69−78.
- Kasprow, W.I., Schachtman, T.R., Miller, R.R. A retrograde gradient for disruption of a conditioned aversion to drinking cold water by ECS administered during the CS-US interval // Physiol. Behav. 1985. — V. 34. — P. 879−882.
- Kato, A., Fukunari, A., Sakai, Y., Nakajima T. Prevention of AmyloidLike Deposition by a Selective Prolyl Endopeptidase Inhibitor, Y-29 794, in
- Senescence-Accelerated Mouse // The Journal of Pharmacology and Experimental Therapeutics. 1997. — V. 283. -N 1. — P. 328−335.
- Kato, Т., Hama, Т., Nagatsu, Т., Kuzuya, H., Sakakibara S. Changes of X-prolyl dipeptidyl-aminopeptidase activity in developing rat brain //Experientia -1979. V.35. — N 10. — P. 1329−1330.
- Kavaliers, M., Choleris, E., Pfaff, DW. Recognition and avoidance of the odors of parasitized conspecifics and predators: differential genomic correlates// Neurosci Biobehav Rev. 2005. — V. 29.-N 8. — P. 1347−1359.
- Kesner, R.P., Crutcher, K.A., Measom MO., Medial septal and nucleus basalis magnocellularis lesions produce order memory deficits in rats which mimic symptomatology of Alzheimer’s disease// Neurobiol. Aging. 1986. — V. 7. — N 4. — P.287−295.
- Kesner, R.P., McGonaugh J., Doty R.W. Diminished amnestic effect of a second electroconvulsive seizure // Exp.Neurol. 1970. — V.27. — P. 224−227.
- Khutoryan, B.M. Quantitative characterization of the cellular elements of human cerebellar nuclei at different ages // Neurosci Behav Physiol. 2005. — V. 35.-N 1.- P. 5−7.
- Konig, J.F.R., Klippel, R.A. The rat brain: A stereotaxic atlas of the forebrain and lower parts of the brain stem. 1st ed. Baltimore: The Williams and Wilkins Company.- 1963.- 279c.
- Kong, L.N., Zuo, P.P., Mu, L., Liu, Y.Y., Yang, N. Gene expression profile of amyloid beta protein-injected mouse model for Alzheimer disease // Acta Pharmacol Sin. 2005. — V. 26. -V. 6. — P. 666−672.
- Kopelman, M.D. Rates of forgeting in DAT and KS // Neuropsychol. 1985. -V. 23.-P. 623 — 638.
- Kopelman, M. D., Lishman, W. A. Pharmacological Treatments of Dementia (non-cholinergic) // British Medical Bulletin. 1986. — V. 42. — P. 101−105.
- Kopelman, M.D. The cholinergic neurotransmitter system in human memory and dementia: a review. // Quart J. Exp. Psychol. 1986. — V.38. — P. 535−573.
- Kopelman, M.D. Amnesia: organic and psychogenic. //Br. J. Psych. 1987. -V. 150. — P. 428−442.
- Kopelman, M.D. Disorders of memory //Brain. 2002. — V.125. — P. 21 522 190.
- Kozlowski, M.R., Arbogast, R.E. Specific toxic effects of ethylcholine nitrogen mustard on cholinergic neurons of the nucleus basalis of Meynert// Brain Res. 1986. — V. 372. -N.l. — P. 45−54.
- Kovacs, A., Telegdy, G. Effect of CGRP on Passive Avoidance Behavior in Rats. // Physiol. Behav. 1995. — V.58. — N 3. — P. 429−435.
- Kumar, К. В., Karanth, К. S. Effects of ACTH and ACTH 4−10 on aversive memory retrieval in rats. // Journal of Neural Transmission. 1995. — V. 101. -N 1−3. — P. 223−229.
- Kumor, V., Calach, M. Treatment of Alzheimer’s disease with cholinergic drugs. //Int. J. Clin. Phann. Ther. Toxicol. 1991. -V.29. — N 1. — P. 23−37.
- Laitinen, K.S., van Groen, Т., Tanila, H., Venalainen, J., Mannisto, P.Т.,
- Alafuzoff IBrain prolyl oligopeptidase activity is associated with neuronal damage rather than beta-amyloid accumulation // Neuroreport. — 2001. V. 12.-N 15.-P. 3309−3312.
- Lee, J., Chai, S.Y., Mendelsohn, F.A., Moms, M.J., Allen, A.M. Potentiation of cholinergic transmission in the rat hippocampus by angiotensin IV and LVV-hemorphin-7 // Neuropharmacology. 2001. — V. 40. — N 4. — P. 618−623.
- Levdikova, G.A., Orekhovich, V.N. On a collagenase-lilce enzyme detected in the extracts of hypothalamus and hypophysis // Clin. Chim. Acta. 1972. -V.42.-N1.-P. 205−208.
- Lin, S., Boey D., Herzog H. NPY and Y receptors: lessons from transgenic and knockout models // Neuropeptides. 2004. — V. 38. — N 4. — P. 189−200.
- Litvan, I. Memory impairment in patients with progressive supranuclear palsy. // Arch. Neurol. 1989. -V.46. — N 8. — P. 765−767.
- Lockwood, K.A., Alexopoulos, G.S., Kakuma, Т., Van Gorp, W.G. Subtypes of cognitive impairment in depressed older adults // Am. J. Geriatr Psychiatry. 2000. — V. 8. — N 3. — P. 201−208.
- Lopez, O.L., Becker, J.T. Extrapyramidal signs in patients with Alzheimer’s disease. /In: Research and Practice in Alzheimer’s Disease 1999. — V.2. -P.206−211.
- Lorrio, S., Sobrado., M, Arias E, Roda JM, GarcHa AG, Lypez MG. Galantamine postischemia provides neuroprotection and memory recovery against transient global cerebral ischemia in gerbils // J. Pharmacol. Exp. Ther. -2007. V. 322.-N2.-P.591−599.
- Love, J. A., Go, V. L. W., Szurszewski, J. H. Vasoactive Intestinal Peptide and Other Peptides as Neuromodulators of Colonic Motility in the Guinea Pig // Annals of the New York Academy of Sciences. 1988. — V.527. — N 1. — P. 360−368.
- Lowry, C.A., Moore, F.L. Regulation of behavioral responses by corticotropin-releasing factor // Gen. Сотр. Endocrinol. 2006. — V. 146. — N l.-P. 19−27.
- Lynch, M. A. Long-Term Potentiation and Memory // Physiol. Rev. 2004. -V.84.-P. 87−136.
- Lynch, M.A., Voss, K.L., Gower, A J. Impaired spatial memory in aged rats is associated with alterations in inositol phospholipid metabolism // Neuroreport. 1994. -V. 5. — N 12. — P. 1493−1497.
- Mannisto, P.T., Venalainen, J/, Jalkanen, A, Garcfa-Horsman Prolyl oligopeptidase: a potential target for the treatment of cognitive disorders // Drug News Perspect. 2007. -V. 20. -N. 5 — P. 293−305.
- Mantle, D, Perry, EK. Comparison of aminopeptidase, dipeptidyl aminopeptidase and tripeptidyl aminopeptidase activities in brain tissue from normal and Alzheimer’s disease cases // J. Neurol. Sci. 1990 — V. 98 — N. 1. -P. 13−20.
- Martin, K.C., Barad, M., Kandel, E.R. Local protein synthesis and its role in synapse-specific plasticity // Currr. Opin Neurobiol. 2000. V. 10. — N 5. — P. 587−592.
- McEwen, B.B. Closing remarks: review and commentary on selected aspects of the roles of vasopressin and oxytocin in memory processing // Adv Pharmacol. 2004 — V. 50 — P. 593−654, 655−708.
- McGaugh JL. The perseveration-consolidation hypothesis: Mueller and Pilzecker, 1900//Brain Res. Bull. 1999.-V. 50.-N5−6.-P. 445−446.
- McGaugh, J.L. Memory a Century of Consolidation. // Science. — 2000. -V. 287. — P. 248−251.
- McGaugh, J.L. Memory consolidation and the amygdala: a systems perspective // Trends Neurosci. 2002. — V. 25. — N 9. — P. 456.11
- Mentlein, R. Dipeptidyl-peptidase IV (CD26)~role in the inactivation of regulatory peptides // Regul. Pept. 1999. — V. 85 — N 1 — P. 9−24.
- Milekic, M.H., Alberini, S.M. Temporally graded requirement for protein synthesis following memory reactivation // Neuron. 2002. V. 36. — P. 521 525.
- Milner, B. The medial temporal-lobe amnesic syndrome // Psychiatr Clin North Am. 2005. V. 28. — N 3. — P. 599−611.
- Minger, S. L, Esiri, M.M., McDonald, В., Keene, J., Carter, J., Hope, Т., Francis, P.T. Cholinergic deficits contribute to behavioral disturbance in patients with dementia // Neurology. 2000. — V.55. — N 10. — P. 1460−1467.
- Morris, R.G. Elements of a neurobiological theory of hippocampal function: the role of synaptic plasticity, synaptic tagging and schemas // Eur J. Neurosci. -2006. V. 23.-N 11.-P. 2829−2846.
- Moscrip, T.D., Terrace., H.S., Sackeim, H.A., Lisanby, S.H.
- A primate model of anterograde and retrograde amnesia p roduced by convulsive treatment // J ЕСТ. 2004. V. 20. — N 1. — P. 26−36.
- Molchan, S.E., Mellow, A.M., Lawlor, B.A., Weingartner, H.J., Cohen, R.M., Cohen, M.R., Sunderland, T. TRH attenuates scopolamine-induced memory impairment in humans // Psychopharmacology (Berl). 1990. — V. 100 — N 1. -P. 84−89.
- Muller, G., Pilzecker, A. Experimentelle beitrage zur lehre vom gedachtni // Z.Physiol. Sinnesorg. Erganzungsband. 1900.-V. l.-P. 1−18.
- Mungas, D., Reed, B. R, Jagust, W.J., DeCarli C., Mack WJ, Kramer JH, Weiner MW, Schuff N, Chui HC. Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease. Neurology 2002. — V. 59. -P. 867−873.
- Mucoz, E., Blazquez, M.V., Madueco, J.A., Rubio, G., Peca, J. CD26 induces T-cell proliferation by tyrosine protein phosphorylation.// Immunology. 1992.- V. 77. — N 1. — P.43−50.
- Murali, G., Panneerselvam, C. Age-associated' oxidative macromolecular damages in rat brain regions: role of glutathione monoester /'/ J.- Gerontol A Biol. Sci Med Sci. 2007. — V. 62. — N 8. — P. 824−30.
- Myohanen TT, Venalainen JI, Garcia-Horsman JA, Piltonen M, Mannisto PT.
- Cellular and subcellular distribution of rat brain prolyl oligopeptidase and its association with specific neuronal neurotransmitters // J. Сотр. Neurol. -2008 -V. 507.-N 5-P. 1694−1708.
- Myohanen TT, Venalainen Л, Tupala E, Garcia-Horsman JA, Miettinen R,
- Mannisto PT. Distribution of immunoreactive prolyl oligopeptidase in human and rat brain //Neurochem Res. 2007 V. 32 — N 8 — P. 1 365 136 574.
- Nagai, Т., Yamada, K., Kim, H., Kim, Y., Noda, Y., Imura, A., Nabeshima, Y., Nabeshima, T. Cognition impairment in the genetic model of aging klotho gene mutant mice: a role of oxidative stress // The FASEB Journal 2007. — V. 21, — N9.- P. 2135 — 2148.
- Nakamura, S., Koshimura, K., Kato, Т., Yamao, S., Iijima, S., Nagata, H., Miyata, S., Fujiyoshi, K., Okamoto, K., Suga, H. Neurotransmitters in dementia // Clin. Ther. 1984 — V.7 — Spec N. 18−34.
- Ogren, S. O, Schijtt PA, Kehr J, Misane I, Razani H. Galanin and learning // Brain Res. 1999. -V. 848.-N 1−2-P. 174−182
- Ohinata, K., Sonoda, S., Inoue, N., Yamauchi, R., Wada, K., Yoshikawa, M. в-Lactotensin, a neurotensin agonist peptide derived from bovine в-lactoglobulin, enhances memory consolidation in mice // Peptides. 2007. — V. 28,-N7.-P. 1470−1474.
- Omura T, Nabekura J, Akaike N. Intracellular pathways of V (l) and V (2) receptors activated by arginine vasopressin in rat hippocampal neurons // J. Biol. Chem.- 1999. V. 274.-N 46. — 32 762−32 770.
- Orlowska-Majdak, M., Naziemblo, В., Kolodziejski, P. Influence of thyrotropin-releasing hormone (TRH) dialyzed into the hippocampus on memory processes in rabbit // Acta Neurobiol Exp (Wars). 2007. — V. 67. — N l.-P. 53−62.
- Orlowski, M., Wilk, E., Pearce, S., Wilk, S. Purification and properties of a prolyl endopeptidase from rabbit brain // J Neurochem. 1979. — V.33 -N 2 -461−469.
- Otmakhova, N. A., Lisman, J. E. D1/D5 Dopamine Receptor Activation Increases the Magnitude of Early Long-Term Potentiation at CA1 Hippocampal Synapses//J. Neuroscience. 1996. — V.16 — N 23 — P. 7478−7486.
- Paizanis E., Hamon M., Lanfumey L. Hippocampal neurogenesis, depressive disorders, and antidepressant therapy // Neural. Plasticity. 2007. -ID73754. -P.l-7.
- Pakkenberg, В., Pelvig, D., Marner, L., Bundgaard, M.J., Gundersen, H.J., Nyengaard, J.R., Regeur, L. Aging and the human neocortex // Exp. Gerontol. -2003. V. 38. — N 1−2. — P. 95−99.
- Park, Y.S., Jang, H.J., Lee, K.H., Hahn, T.R., Paik, Y.S. Prolyl endopeptidase inhibitory activity of unsaturated fatty acids // J. Agric. Food Chem. 2006.- V. 4.-N4.-P. 1238−1242.
- Phillips, A.G., Pfaus, J.G., Blaha, C.D. Dopamine and motivated behavioninsights provided in vivo analysis. The Mesolimbic Dopamine System: from Motivation to Action / Eds Willner P. and Scueel-Kruger J. Chichester, UK: Willey. 1991. — P. 199−224.
- Power, A.E. Muscarinic cholinergic contribution to memory consolidation: with attention to involvement of the basolateral amygdale // Curr. Med. Chem.-2004. V. 11. -N 8. — P. 987−996.
- Quartermain, D., McEwen, B.S., Azmitia, E.C. Recovery of memory following amnesia in the rat and mouse // J. Comp.Physiol.Psychol. 1972. — V. 79.-P. 360−370.
- Quinton, E.E., Kramarcy, N.R. Memory impairment correlates closely with cyclogehimide dose and degree of inhibition of protein synthesis // Brain Res. -1997.-V. 131 P. 184−190.
- Rainbow, T.C., Flexner, L.B. Studies on memory: spontaneous return of memory in 6-hydroxydopamine-treated mice and the relation to cycloheximide-induced transient amnesia // Pharmacol. Biochem. Behav. 1978. — Vol. 8. — P. 1−5.
- Redrobe, J.P., Dumont, Y., Herzog, H., Quirion, R. Characterization of neuropeptide Y, Y (2) receptor knockout mice in two animal models of learning and memory processing // J. Mol Neurosci. 2004. — V. 22. -N 3. — P. 159−166.
- Rempel-Clower, N.L., Zola, S. M, Squire, L.R., Amaral, D.G. Three cases of enduring memory impairment after bilateral damage limited to the hippocampal formation.//J. Neurosci. 1996.-V. 15-N 16 P.5233−5255.
- Ritchie R., Lovestone S. The dementias // Lancet. 2002. — V.360 — N 9347. P.1759−1766.
- Rose, S.P.R. Biochemical mechanisms involved in memory formation in the chick // Behavioral and Neural Plasticity: the Use of a Domestic Chick as a Model /Ed. Andrew R.J. Oxford: Oxford Univ. Press. 1991. — P.277−304.
- Rosenblum, J. S., Kozarich, J.W. Prolyl peptidases: a serine protease subfamily with high potential for drug discovery // Current Opinion in Chemical Biology. 2003. — V. 7- P. 496−504.
- Rosmaninho-Salgado J, Araujo IM, Alvaro AR, Duarte EP, Cavadas C. Intracellular signaling mechanisms mediating catecholamine release upon activation of NPY Y1 receptors in mouse chromaffin cells // J. Neurochem. 2007-V.103-N3 P.896−903.
- Rossner, S., Schulz, I., Zeitschel, U., Schliebs, R., Bigl, V., Demuth, H. Brain Prolyl Endopeptidase Expression in Aging, APP Transgenic Mice and Alzheimer’s Disease. // Neurochem. Res. 2005. — V. 30. — N 6−7. — P. 695 702.
- Salam A.O.M. Vinpocetine and piracetam exert antinociceptive effect in visceral pain model in mice // Pharmaco. l Rep. 2006. — V. 58. — N 5. P. 680 691.
- Salamone, J.D., Cousins, M.S., Snyder, B.J. Behavioral functions of nucleus accumbens dopamine: empirical and conceptual problems with the anhedonia hypothesis // Neurosci. Biobehav. Rev. 1997. — V.21. — N 3. — P.341−359.
- Salgado-Pineda P, Delaveau P, Blin O, Nieoullon A. Dopaminergic contribution to the regulation of emotional perception // Clin. Neuropharmacol. 2005. — V. 28. — N 5. — P. 228−237.
- Sara, S. J., Hars, B. In memory of consolidation // Learn. Mem. 2006. -V.13-P. 515−521.
- Scharpe, S., De Meester, I., Verh, K. Peptide truncation by dipeptidyl peptidase IV: a new pathway for drug discovery? // Acad Geneeskd Belg. 2001 V. 63. — N 1- P. 5−32- discussion 32−33.)
- Schlesinger, K., Lipsitz, D.U., Peck, P.L., Pelleymounter, M.A., Stewart, J.M., Chase, T.N. Substance P reversal of electroconvulsive shock and cycloheximide-induced retrograde amnesia // Behav Neural Biol. —1983a. V. 39, — N 1. — P.30−39.
- Schlesinger, К., Lipsitz, D.U., Peck, P.L., Pelleymounter, M.A., Stewart, J.M., Chase, T.N. Substance P enhancement of passive and active avoidance conditioning in mice. // Pharmacol Biochem Bhav. 1983b — V. 19 -N 4. -P655−561.
- Schulz, I., Gerhartz, В., Neubauer, A., Holloschi, A., Heiser, U., Hafner, M., Demuth HU. Modulation of inositol 1,4,5-triphosphate concentration by prolyl endopeptidase inhibition. // Eur. J. Biochem. 2002. — V. 269. — N 23. — P.813−820.
- Sedo, A., Malik, R. Dipeptidyl peptidase IV-like molecules: homologous proteins or homologous activities? // BBA 1550 2001. — P. 107−116.
- Shishido Y, Furushiro M, Tanabe S, Shibata S, Hashimoto S, Yokokura T. Effects of prolyl endopeptidase inhibitors and neuropeptides on delayed neuronal death in rats// Eur J Pharmacol. 1999. — V. 372 — P. 135−142.
- Sikstrom, S. Computational perspectives on neuromodulation of aging //Acta Neurochir. Suppl. 2007. — V. 97. — Pt 2. — P.513−518.
- Small, S.A. Age-related memory decline: current concepts and future directions //Arch Neurol. 2001. — V. 58. -N 3. — P. 360−364.
- Smyth, M., O’Cuinn, G. Dipeptidyl aminopeptidase activities of guinea-pig brain // Int. J. Biochem. 1994. — V. 26. — N 7. — 913−921.
- Squire, L.R. Lost forever or temporarily misplaced? The long debate about the nature of memory impairment // Learn. Mem. 2006. — V. 13 — P. 522−529.
- Squire, L.R., Clark, R.E., Knowlton, B.J. Retrograde amnesia // Hippocampus.-2001. — V. 11 N 1.-P.50−55.
- Stevens, Т., Livingston, G., Kitchen, G., Manela, M., Walker, Z., Katona, C. Islington study of dementia subtypes in the community // Br. J. Psychiatry. — 2002.- V. 180.-P. 270−276.
- Strand, F.L., Lee, S.J., Lee, T.S., Zuccarelli, L. A, Antonawich, F.J., Kume, J., Williams, K.A. Non-corticotropic ACTH peptides modulate nerve development and regeneration // Rev Neurosci. 1993. — V. 4. — N 4. — P.321−363.
- Sullivan, J.M. Cellular and Molecular Mechanisms Underlying Learning and Memory Impairments Produced by Cannabinoids // Learn. Mem. 2000. -V. 7- P. 132−139.
- Terwel, D., Bothmer, J., Wolf, E., Meng, F., Jolles, J. Affected enzyme activities in Alzheimer’s disease are sensitive to antemortem hypoxia. // J. Neurol. Sci. -1998. V. 161.-N l.-P. 47−56.
- Terwel, D., Markerink, M., Jolles, J. Peptidases are affected differently in neocortical regions of brains from patients with Alzheimer’s Disease // Dementia. 1992. — V.3. — N 2. — P.108−113.
- Toide, K., Iwamoto, Y., Fujiwara, Т., Abe, H. JTP-4819: a novel prolyl endopeptidase inhibitor with potential as a cognitive enhancer. // J. Pharmacol. Exp. Ther.- 1995.-V. 274-N3.-P. 1370−1378.
- Toide, K., Fujiwara, Т., Iwamoto, Y., Shinoda, M., Okamiya, K., Kato, T. Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on neuropeptide metabolism in the rat brain //Naunyn Schmiedebergs Arch Pharmacol. 1996.-V. 353 -N3.- P. 355−362.
- Toide, K, Shinoda, M, Fujiwara, T, Iwamoto, Y. Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on spatial memory and central cholinergic neurons in aged rats // Pharmacol Biochem. Behav. 1997. — V. 56. — N 3 — P. 427−434.
- Toide, K., Shinoda, M., Iwamoto, Y., Fujiwara, Т., Okamiya, K., Uemura, A. A novel prolyl endopeptidase inhibitor, JTP-4819, with potential for treating
- Alzheimer’s disease 11 Behavioural Brain Research 1997b. — V. 83. — N 1. — P. 147−151.
- Toni, R., Jackson, I. M, Lechan, R.M. Neuropeptide-Y-immunoreactive innervation of thyrotropin-releasing hormone-synthesizing neurons in the rat hypothalamic paraventricular nucleus // Endocrinology. 1990 — V. 26. — N 5. -P. 2444−2453.
- Trudeau, L.E., Guti6rrez, R. On cotransmission & neurotransmitter phenotype plasticity // Mol Interv. 2007. — V. 7. — N 3. — P. 138−146.
- Turk, B. Targeting proteases: successes, failures and future prospects // Nature Rev. 2006. — V.5. — P.785−798.
- Ukai, M., Shan-Wu, X., Kobayashi, Т., Kameyama, T. Systemic administration of dynorphin A-(l-13) markedly improves cycloheximide-induced amnesia in mice. // Eur J. Pharmacol. 1996. — V. 313. — N 1−2. — P. 11−15.
- Ungerleider, L.G. Functional brain imaging studies of cortical mechanisms for memory // Science. 1995. — V. 270. — N 5237. — P. 769−775.
- Vanhoof, G., Goossens, F., De Meester, I., Hendriks, D., Scharpe, S. Proline motifs in peptides and their biological processing // Fabes. 1995. — V. 9. — N 9. — P. 736−744.
- Valenti, G. Neuropeptide changes in dementia: pathogenetic implications and diagnostic // Gerontology 1996. — V. 42. — N 5. — P. 241−256.
- Valentino, R.J., Commons, K.G. Peptides that fine-tune the serotonin system. //Neuropeptides. 2005. — V. 39. — N 1. — P. 1−8.
- Voronina, T.A. Nootropic drugs in Alzheimer disease treatment. New Pharmacological Strategies / Alzheimer disease: therapeutic strategies.-Giacobini E., Becker eds.-Birkhauser-Boston, 1994- P. 265−269.
- Walter, R., Shlank, H., Glass, J.D., Shwartz, I.L., Kerenyi, T.D. Leucylglycinamide released from oxytocin by human uterine enzyme // Science- 1971. V.173. — P.827−829.
- Wang, Q., Wang, J. Injection of bradykinin or cyclosporine A to hippocampus induces Alzheimer-like phosphorylation of Tau and abnormal behavior in rats. // Chin Med J (Engl). 2002. — V. 115. — N 6. — P. 884−887.
- Warnock, G., Prickaerts, J., Steckler, T. Interactions between CRF and acetylcholine in the modulation of cognitive behaviour // EXS. 2006. — V. 98.- P.41−63.
- Welches, W.R., Santos, R.A., Chappell, M.C., Brosnihan, K.B." Greene, L.J., Ferrario, C.M. Evidence that prolyl endopeptidase participates in the processing of brain angiotensin // J. Hypertens. 1991. — Vol. 9. — P.631−638.
- Wenk, G.L. Neuropathologic changes in Alzheimer’s disease: potential targets for treatment // J. Clin Psychiatry. 2006. — V. 67. — Suppl 3. — P. 3−7.
- Wingen, M, Kuypers, K.P., Ramaekers, J.G. Selective verbal and spatial memory impairment after 5-HT1A and 5-HT2A receptor blockade in healthy volunteers pre-treated with an SSRI. // J. Psychopharmacol. 2007. — V. 21. — N 5. — P. 477−485.
- Winocur, G., McDonald, R.M., Moscovitch, M. Anterograde and retrograde amnesia in rats with large hippocampal lesions // Hippocampus. 2001 — V. 11. — N 1. — P. 18−26.
- Yamaguchi, Y., Kobayashi, H. Effects of vasoactive intestinal peptide (VIP) on scopolamine-induced amnesia in the rat // Neuropeptides. 1994. — V. 26. -N.3 — P.153−158.
- Yamamoto, M., Chikuma, T" Kato, T. Changes in the levels of neuropeptides and their metabolizing enzymes in the brain regions of nucleus basalis magnocellularis-lesioned rats // J. Pharmacol. Sci. 2003 — V. 92 N.4 -P. 400−410.
- Yarbrough, G.G., Pomara, N. The therapeutic potential of thyrotropin releasing hormone (TRH) in Alzheimer’s disease (AD) // Prog. Neuropsychopharmacol Biol. Psychiatry. 1985 — V. 9 — N 3 — P. 285−289.
- Yehuda, S., Carasso, R.L., Mostofsky, D.I. The facilitative effects of alpha-MSH and melanin on learning, thermoregulation, and pain in neonatal MSG-treated rats // Peptides. 1991- V. 12 -N 3. — P. 465−469.
- Yehuda S. Effects of alpha-MSH, TRH and AVP on learning and memory, pain threshold, and motor activity: preliminary results. // Int. J. Neurosci. -1987. V. 32. — N 3−4. — 703−709.
- Yoshimoto, Т., Fischl, M., Orlowski, R.C., Walter, R. Post-proline cleaving enzyme and post-proline dipeptidyl aminopeptidase // J. Biol. Chem. 1978. -V.253.-P. 3708−3716.
- Yoshimoto, Т., Kado, K., Matsubara, F., Koriyama, N., Kaneto, H., Tsuru, D. Specific inhibitors for prolyl endopeptidase and their anti-amnesic effect // Journal of Pharmacobio-Dynamics 1987. — V.10. — P.730−735.
- Zhao, W., Sedman, G., Gibbs, M., Ng, К. T. Phosphorylation changes following weakly reinforced learning and ACTH-induced memory consolidation for a weak learning experience // Brain res. bull.- 1995. -V. 36.-N2.-P. 161−168.1. Ъ^у (S)
- Zola-Morgan, S., Squire, L.R. Neuroanatomy of memory 11 Ann. Rev. Neurosci. 1993. — V. 16. — P. 547−5 63.